CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 141 enrolled
Drug / intervention
Continuous Glucose Monitoring Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02671968
NCT02671968N/ACompleted
CompareCT.gov

Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)

Science Consulting in Diabetes·interventional·Posted Feb 2, 2016·Updated Mar 12, 2018

In Brief

A clinical study evaluating Continuous Glucose Monitoring System for Diabetes. Completed, enrolled 141 participants across 12 sites.

Detailed Summary

Demonstrate that usage of RT-CGM (Real time continuous glucose monitoring) reduces the frequency of low CGM-recorded glucose events in patients using MDI (Multiple daily injections) that are at risk for hypoglycemic events.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesGermany
CollaboratorsDexCom, Inc. a Delaware corporation, USA, Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 2, 2016
Enrollment StartFeb 1, 2016
Primary CompletionJul 14, 2017
Study CompletionOct 24, 2017
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 10.4 years ago

Interventions

Continuous Glucose Monitoring Systemdevice